Related references
Note: Only part of the references are listed.Arrhythmogenic Cardiomyopathy: Etiology, Diagnosis, and Treatment
Srijita Sen-Chowdhry et al.
ANNUAL REVIEW OF MEDICINE (2010)
Activation of cardiac hypertrophic signaling pathways in a transgenic mouse with the human PRKAG2 Thr400Asn mutation
Sanjay K. Banerjee et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2010)
Peripartum Cardiomyopathy as a Part of Familial Dilated Cardiomyopathy
Karin Y. van Spaendonck-Zwarts et al.
CIRCULATION (2010)
Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia Proposed Modification of the Task Force Criteria
Frank I. Marcus et al.
CIRCULATION (2010)
Metabolic Modulator Perhexiline Corrects Energy Deficiency and Improves Exercise Capacity in Symptomatic Hypertrophic Cardiomyopathy
Khalid Abozguia et al.
CIRCULATION (2010)
DNA testing for hypertrophic cardiomyopathy: a cost-effectiveness model
Sarah Wordsworth et al.
EUROPEAN HEART JOURNAL (2010)
Cardiac fibrosis in mice with hypertrophic cardiomyopathy is mediated by non-myocyte proliferation and requires Tgf-β
Polakit Teekakirikul et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Cardiac signaling genes exhibit unexpected sequence diversity in sporadic cardiomyopathy, revealing HSPB7 polymorphisms associated with disease
Scot J. Matkovich et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Increased myofilament Ca2+-sensitivity and arrhythmia susceptibility
Sabine Huke et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2010)
Compound and Digenic Heterozygosity Contributes to Arrhythmogenic Right Ventricular Cardiomyopathy
Tianhong Xu et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Familial Dilated Cardiomyopathy Caused by an Alpha-Tropomyosin Mutation The Distinctive Natural History of Sarcomeric Dilated Cardiomyopathy
Neal K. Lakdawala et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Clinical Features and Outcome of Hypertrophic Cardiomyopathy Associated With Triple Sarcomere Protein Gene Mutations
Francesca Girolami et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Mutations in Alpha-Actinin-2 Cause Hypertrophic Cardiomyopathy A Genome-Wide Analysis
Christine Chiu et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Prognostic Significance of Myocardial Fibrosis in Hypertrophic Cardiomyopathy
Rory O'Hanlon et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Dilated cardiomyopathy
John Lynn Jefferies et al.
LANCET (2010)
New Therapeutic Approaches to Mendelian Disorders
Harry C. Dietz
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Myocardial Fibrosis as an Early Manifestation of Hypertrophic Cardiomyopathy
Carolyn Y. Ho et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
AMP-activated protein kinase: a core signalling pathway in the heart
A. S. Kim et al.
ACTA PHYSIOLOGICA (2009)
A potential link between peroxisome proliferator-activated receptor signalling and the pathogenesis of arrhythmogenic right ventricular cardiomyopathy
Fatima Djouadi et al.
CARDIOVASCULAR RESEARCH (2009)
Cardiac Myosin-Binding Protein C Mutations and Hypertrophic Cardiomyopathy Haploinsufficiency, Deranged Phosphorylation, and Cardiomyocyte Dysfunction
Sabine J. van Dijk et al.
CIRCULATION (2009)
Genetic Fate Mapping Identifies Second Heart Field Progenitor Cells As a Source of Adipocytes in Arrhythmogenic Right Ventricular Cardiomyopathy
Raffaella Lombardi et al.
CIRCULATION RESEARCH (2009)
Evidence From Human Myectomy Samples That MYBPC3 Mutations Cause Hypertrophic Cardiomyopathy Through Haploinsufficiency
Steven Marston et al.
CIRCULATION RESEARCH (2009)
Lamin A/C deficiency as a cause of familial dilated cardiomyopathy
Rohit Malhotra et al.
CURRENT OPINION IN CARDIOLOGY (2009)
Mutations in the ANKRD1 gene encoding CARP are responsible for human dilated cardiomyopathy
Laetitia Duboscq-Bidot et al.
EUROPEAN HEART JOURNAL (2009)
Diagnostic Yield, Interpretation, and Clinical Utility of Mutation Screening of Sarcomere Encoding Genes in Danish Hypertrophic Cardiomyopathy Patients and Relatives
Paal Skytt Andersen et al.
HUMAN MUTATION (2009)
Clinical Outcome and Phenotypic Expression in LAMP2 Cardiomyopathy
Barry J. Maron et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
The Effects of Candesartan on Left Ventricular Hypertrophy and Function in Nonobstructive Hypertrophic Cardiomyopathy A Pilot, Randomized Study
Martin Penicka et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2009)
Cardiac Ankyrin Repeat Protein Gene (ANKRD1) Mutations in Hypertrophic Cardiomyopathy
Takuro Arimura et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
A common MYBPC3 (cardiac myosin binding protein C) variant associated with cardiomyopathies in South Asia
Perundurai S. Dhandapany et al.
NATURE GENETICS (2009)
Myofilament Protein Gene Mutation Screening and Outcome of Patients With Hypertrophic Cardiomyopathy
Iacopo Olivotto et al.
MAYO CLINIC PROCEEDINGS (2009)
A New Diagnostic Test for Arrhythmogenic Right Ventricular Cardiomyopathy.
Angeliki Asimaki et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Arrhythmogenic right ventricular cardiomyopathy type 5 is a fully penetrant, lethal arrhythmic disorder caused by a missense mutation in the TMEM43 gene
Nancy D. Merner et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2008)
Mutations in sarcomere protein genes in left ventricular noncompaction
Sabine Klaassen et al.
CIRCULATION (2008)
Beyond the sarcomere:: CSRP3 mutations cause hypertrophic cardiomyopathy
Christian Geier et al.
HUMAN MOLECULAR GENETICS (2008)
Transcriptional deregulation and a missense mutation define ANKRD1 as a candidate gene for total anomalous pulmonary venous return
Raffaella Cinquetti et al.
HUMAN MUTATION (2008)
Lamin A/C haploinsufficiency causes dilated cardiomyopathy and apoptosis-triggered cardiac conduction system disease
Cordula M. Wolf et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2008)
The familial hypertrophic cardiomyopathy-associated myosin mutation R403Q accelerates tension generation and relaxation of human cardiac myofibrils
Alexandra Belus et al.
JOURNAL OF PHYSIOLOGY-LONDON (2008)
Long-term outcome and risk stratification in dilated cardiolaminopathies
Michele Pasotti et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Tackling heart failure in the twenty-first century
James O. Mudd et al.
NATURE (2008)
The genetics of hypertrophic cardiomyopathy: Teare redux
H. Watkins et al.
HEART (2008)
Classification of the cardiomyopathies: a position statement from the european society of cardiology working group on myocardial and pericardial diseases
Perry Elliott et al.
EUROPEAN HEART JOURNAL (2008)
Prevalence of Fabry disease in a cohort of 508 unrelated patients with hypertrophic cardiomyopathy
Lorenzo Monserrat et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Dilated and hypertrophic cardiomyopathy mutations in troponin and α-tropomyosin have opposing effects on the calcium affinity of cardiac thin filaments
Paul Robinson et al.
CIRCULATION RESEARCH (2007)
Metabolic mechanisms in heart failure
Houman Ashrafian et al.
CIRCULATION (2007)
Hypertrophic and dilated cardiomyopathy mutations differentially affect the molecular force generation of mouse α-cardiac myosin in the laser trap assay
Edward P. Debold et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
Prevalence, clinical significance, and genetic basis of hypertrophic cardiomyopathy with restrictive phenotype
Toru Kubo et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Mutations in JPH2-encoded junctophilin-2 associated with hypertrophic cardiomyopathy in humans
Andrew P. Landstrom et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2007)
Evidence for microvascular dysfunction in hypertrophic cardiomyopathy - New insights from multiparametric magnetic resonance imaging
Steffen E. Petersen et al.
CIRCULATION (2007)
Computational simulation of hypertrophic cardiomyopathy mutations in Troponin I: Influence of increased myofilament calcium sensitivity on isometric force, ATPase and [Ca2+](i)
Aya Kataoka et al.
JOURNAL OF BIOMECHANICS (2007)
Wide spectrum of presentation and variable outcomes of isolated left ventricular non-compaction
C. Lofiego et al.
HEART (2007)
Age- and training-dependent development of arrhythmogenic right ventricular cardiomyopathy in heterozygous plakoglobin-deficient mice
Paulus Kirchhof et al.
CIRCULATION (2006)
Phospholamban R14 deletion results in late-onset, mild, hereditary dilated cardiomyopathy
Megan M. DeWitt et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Cardiac myosin missense mutations cause dilated cardiomyopathy in mouse models and depress molecular motor function
Joachim P. Schmitt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Suppression of canonical Wnt/β-catenin signaling by nuclear plakoglobin recapitulates phenotype of arrhythmogenic right ventricular cardiomyopathy
Eduardo Garcia-Gras et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Contemporary definitions and classification of the cardiomyopathies - An American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; And Council on Epidemiology and Prevention
BJ Maron et al.
CIRCULATION (2006)
Arrhythmogenic right ventricular cardiomyopathy type 6 (ARVC6): support for the locus assignment, narrowing of the critical region and mutation screening of three candidate genes
LO Matolweni et al.
BMC MEDICAL GENETICS (2006)
A mutation in the human phospholamban gene, deleting arginine 14, results in lethal, hereditary cardiomyopathy
K Haghighi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Primary prevention of sudden death in patients with lamin A/C gene mutations
C Meune et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Gene mutations in apical hypertrophic cardiomyopathy
M Arad et al.
CIRCULATION (2005)
Compound and double mutations in patients with hypertrophic cardiomyopathy: implications for genetic testing and counselling
J Ingles et al.
JOURNAL OF MEDICAL GENETICS (2005)
Dilated cardiomyopathy mutations in three thin filament regulatory proteins result in a common functional phenotype
M Mirza et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Mutation in the transcriptional coactivator EYA4 causes dilated cardiomyopathy and sensorineural hearing loss
J Schönberger et al.
NATURE GENETICS (2005)
Regulatory mutations in transforming growth factor-β3 gene cause arrhythmogenic right ventricular cardiomyopathy type 1
G Beffagna et al.
CARDIOVASCULAR RESEARCH (2005)
Remodeling of myocyte gap junctions in arrhythmogenic right ventricular cardiomyopathy due to a deletion in plakoglobin (Naxos disease)
SR Kaplan et al.
HEART RHYTHM (2004)
The sensitive giant: the role of titin-based stretch sensing complexes in the heart
MK Miller et al.
TRENDS IN CELL BIOLOGY (2004)
Tcap gene mutations in hypertrophic cardiomyopathy and dilated cardiomyopathy
T Hayashi et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
Mutations in Cypher/ZASP in patients with dilated cardiomyopathy and left ventricular non-compaction
M Vatta et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)
Ascertainment strategies and genotype: Phenotype correlations in hypertrophic cardiomyopathy
E Blair et al.
CIRCULATION (2003)
Prevalence and spectrum of thin filament mutations in an outpatient referral population with hypertrophic cardiomyopathy
SL Van Driest et al.
CIRCULATION (2003)
Hypertrophic cardiomyopathy due to sarcomeric gene mutations is characterized by impaired energy metabolism irrespective of the degree of hypertrophy
JG Crilley et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)
Hypertrophic cardiomyopathy - Distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy
P Richard et al.
CIRCULATION (2003)
Familial hypertrophic cardiomyopathy-linked mutant troponin T causes stress-induced ventricular tachycardia and Ca2+-dependent action potential remodeling
BC Knollmann et al.
CIRCULATION RESEARCH (2003)
Development of left ventricular hypertrophy in adults with hypertrophic cardiomyopathy caused by cardiac myosin-binding protein C gene mutations
BJ Maron et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2001)
Mutations in cis can confound genotype-phenotype correlations in hypertrophic cardiomyopathy
E Blair et al.
JOURNAL OF MEDICAL GENETICS (2001)
Mutations in the γ2 subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy:: evidence for the central role of energy compromise in disease pathogenesis
E Blair et al.
HUMAN MOLECULAR GENETICS (2001)
The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms
JG Seidman et al.
CELL (2001)
Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy
M Kamisago et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Long-term follow-up of 34 adults with isolated left ventricular noncompaction: A distinct cardiomyopathy with poor prognosis
EN Oechslin et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2000)
The final common pathway hypothesis and inherited cardiovascular disease - The role of cytoskeletal proteins in dilated cardiomyopathy
NE Bowles et al.
HERZ (2000)
Mutations in the human delta-sarcoglycan gene in familial and sporadic dilated cardiomyopathy
S Tsubata et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Ca2+ buffering in the heart: Ca2+ binding to and activation of cardiac myofibrils
GA Smith et al.
BIOCHEMICAL JOURNAL (2000)
Share Paper
